- Current report filing (8-K)
2011年5月10日 - 5:16AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): May 9, 2011
DRUGSTORE.COM, INC.
(Exact Name of Registrant as Specified in Charter)
|
|
|
|
|
Delaware
|
|
000-26137
|
|
04-3416255
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File No.)
|
|
(IRS Employer
Identification No.)
|
411 108
th
Ave. NE, Suite 1400, Bellevue, Washington 98004
(Address of Principal Executive Offices, Including Zip Code)
(425) 372-3200
(Registrants Telephone Number, Including Area Code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (
see
General Instruction A.2. below):
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 7.01
|
Regulation FD Disclosure.
|
On May 9,
2011, drugstore.com, inc. issued a press release to report the expiration of the waiting period under the U.S. Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (HSR Act), with respect to the proposed merger previously announced on
March 24, 2011 pursuant to which drugstore.com would be acquired by Walgreen Co. A copy of the press release is attached hereto as Exhibit 99.1.
Item 9.01
|
Financial Statements and Exhibits.
|
|
99.1
|
Press release dated May 9, 2011.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
DRUGSTORE.COM, INC.
(Registrant)
|
|
|
By:
|
|
/s/ Yukio Morikubo
|
|
|
Yukio Morikubo
Vice President, Strategy and General Counsel
|
Date: May 9, 2011
Drugstore (NASDAQ:DSCM)
過去 株価チャート
から 1 2025 まで 2 2025
Drugstore (NASDAQ:DSCM)
過去 株価チャート
から 2 2024 まで 2 2025
Real-Time news about Drugstore.Com, Inc. (MM) (ナスダック市場): 0 recent articles
その他のニュース記事